Randomized Trialhigh evidence
Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND.
JAMA·November 7, 2026·PMID 42998244
Why it mattersFor patients with stable coronary disease and moderate-to-severe ischemia, the decision between routine invasive management and initial medical therapy has been debated. This long-term follow-up provides robust evidence that an initial invasive strategy does not confer a survival advantage over a conservative approach, informing shared decision-making and guideline recommendations.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled